perinatal maternal depression, antidepressant use and ...then influences maternal cognitive response...
TRANSCRIPT
RESEARCH REPOSITORY
This is the author’s final version of the work, as accepted for publication following peer review but without the publisher’s layout or pagination.
The definitive version is available at:
https://doi.org/10.1016/j.jad.2018.05.025
Galbally, M., Watson, S.J., Teti, D. and Lewis, A.J. (2018) Perinatal maternal depression, antidepressant use and infant sleep outcomes: Exploring cross-lagged associations in a
pregnancy cohort study. Journal of Affective Disorder
http://researchrepository.murdoch.edu.au/id/eprint/40996/
Copyright: © 2018 Elsevier B.V.
It is posted here for your personal use. No further distribution is permitted.
Accepted Manuscript
Perinatal maternal depression, antidepressant use and infant sleepoutcomes: exploring cross-lagged associations in a pregnancy cohortstudy
Megan Galbally , Stuart J. Watson , Doug Teti , Andrew J. Lewis
PII: S0165-0327(18)30396-3DOI: 10.1016/j.jad.2018.05.025Reference: JAD 9801
To appear in: Journal of Affective Disorders
Received date: 23 February 2018Revised date: 12 April 2018Accepted date: 18 May 2018
Please cite this article as: Megan Galbally , Stuart J. Watson , Doug Teti , Andrew J. Lewis , Perina-tal maternal depression, antidepressant use and infant sleep outcomes: exploring cross-lagged associ-ations in a pregnancy cohort study, Journal of Affective Disorders (2018), doi: 10.1016/j.jad.2018.05.025
This is a PDF file of an unedited manuscript that has been accepted for publication. As a serviceto our customers we are providing this early version of the manuscript. The manuscript will undergocopyediting, typesetting, and review of the resulting proof before it is published in its final form. Pleasenote that during the production process errors may be discovered which could affect the content, andall legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
1
Highlights
No reciprocal associations between maternal depression and infant sleep problems.
Antidepressant exposure not associated with increased infant sleep problems.
Maternal depression not associated with increased infant sleep problems.
Reciprocal longitudinal effects between maternal cognitions and infant waking.
Early maternal cognitions and infant waking predicted later night settling behaviours.
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
2
Perinatal maternal depression, antidepressant use and infant sleep outcomes: exploring
cross-lagged associations in a pregnancy cohort study.
Megan Galbally MBBS, PhD1,2,3
, Stuart J Watson PhD1,2
, Doug Teti PhD4, Andrew J. Lewis
PhD1
Author Affiliations:
1. School of Psychology and Exercise Science, Murdoch University, Australia
2. School of Medicine, University of Notre Dame, Australia
3. King Edward Memorial Hospital, Australia
4. Human Development and Family Studies, The Pennsylvania State University
Corresponding Author:
Professor Megan Galbally Murdoch University, 90- South Street, Murdoch 6150
Email: [email protected] Ph +61-8-9340 2844
Funding
This study is supported through the 2012 National Priority Funding Round of beyondblue in
a three-year research grant (ID 519240) and a 2015 National Health and Medical Research
Council (NHMRC) project grant for 5 years (APP1106823). Financial support has also been
obtained from the Academic Research Development Grants from Mercy Health and from the
Centre for Mental Health and Well-Being, Deakin University.
Declaration of Interest
MG has previously received honorarium for speaking from Lundbeck. The other authors
declare that they have no competing interests.
Abstract
Background: Both perinatal depression and infant sleep problems are common concerns in
many communities, with these problems often coinciding. Findings in this area conflict and
much of the research relies on poor measures of sleep and/or depression. Adding to this
complexity is the rise in antidepressant treatment for perinatal maternal depression and no
previous study has examined the relationship between such exposure and infant sleep.
Methods: This study draws on four waves of data (first and third trimesters, and six and 12
months postpartum) from 264 women in the Mercy Pregnancy and Emotional Wellbeing
Study, a prospective pregnancy cohort study of women recruited in first trimester in
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
3
Melbourne, Australia. Cross-lagged regression models were used to examine reciprocity of
longitudinal effects between depressive symptoms and sleep.
Results: Maternal antepartum depression and antidepressant use were not significant
predictors of infant sleep problems. Likewise, infant sleep problems were not significant
predictors of postpartum maternal depression. However, maternal cognitions about infant
sleep, characterised by maternal expectations to immediately attend to their crying child, did
demonstrate positive reciprocal effects with infant nocturnal waking between six and 12
months postpartum.
Limitations: Infant sleep outcomes were reported by the mother and the sample were
predominantly Anglophone, restricting generalizability of the models to other cultures.
Conclusions: Maternal depression and antidepressant use were not found to be significant
factors in infant sleep problems and, likewise, infant sleep problems were not associated with
maternal depression. However, postpartum maternal cognitions around six months
postpartum regarding limit-setting at night may predict increases in later nocturnal infant
signaling.
Keywords Depression, Antidepressants, Infant Sleep
Abbreviations
AD: Antidepressant; BISQ: Brief Infant Sleep Questionnaire; CFI: Comparative Fit Index;
EPDS: Edinburgh Postnatal Depression Scale; PIBBS: Parental Interactive Bedtime Behavior
Scale; RMSEA: Root Mean Square Error of Approximation; SCID-IV: Structured Clinical
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
4
Interview for the DSM-IV; SRMR: Standardized Root Mean Square; SSRI: Selective
Serotonin Reuptake Inhibitor
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
5
A range of factors including biological, socio-emotional, early parenting practices and
cultural practices, and parental expectations can potentially influence the development of
sleep patterns in infants. For many families there are challenges adjusting to infant sleep
patterns and unsettled infants can adversely affect both parental and infant wellbeing.
However, whether infant sleep patterns can influence the development of maternal depression
remains unclear. In several studies, maternal depression has been implicated as an associated
factor in infant sleep, but the true nature of the relationship between maternal mental health
and infant sleep outcomes is yet to be fully understood.
Studies relying only on maternal reports of depressive symptoms and of infant sleep
outcomes demonstrate a significant association between an infant’s unsettled sleep and
maternal depression. Indeed, unsettled infant sleep may predict maternal depression,
suggesting that interventions aimed at improving infant sleep outcomes may improve
maternal depression (Hiscock and Wake, 2001; Lam et al., 2003). However, research
examining this relationship using observational methods has demonstrated the relationship to
be more complex, with some maternal behaviors associated with depression affecting infant
sleep behaviors such as night waking (Teti and Crosby, 2012). Adding to this complexity,
there are key postpartum variables, such as breastfeeding, often unaccounted for in this area
of research that can influence maternal and infant sleep patterns, and may affect depression
symptoms (Dias and Figueiredo, 2015; Galbally et al., 2013).
Furthermore, the infant sleep outcome can vary from night waking and signaling for
the parent, parental settling behaviors, difficulties going to sleep and sleep location. Defining
the sleep problem is crucial and varies in the research from parental perception of a problem,
numbers of wakes in the night, to the time taken for an infant to fall sleep. For instance, night
waking may be due to infant sleep problems, but equally, may be part of normal feeding
behavior (Galbally et al., 2013). Making sense of current research findings is important given
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
6
potential implications for clinical translation and recommendations, depending on whether
maternal factors or infant factors are stronger in this relationship and the nature of the infant
sleep concern. Teti and Crosby have conceptualized the association between infant sleep and
maternal depression as being either a maternal-driven model or an infant-driven model (Teti
and Crosby, 2012).
The maternal-driven model places the starting point at maternal depression, which
then influences maternal cognitive response and actions around infant sleep and ultimately
influencing infant sleep behaviors. This is supported by increased rates of depression in
mother-infant pairs presenting to early parenting sleep and settling services (Fisher et al.,
2004). It is also supported by prospective research demonstrating maternal depression in
pregnancy is associated with higher reported sleep difficulties in infants (Field et al., 2007;
Nevarez et al., 2010). Likewise, a systematic review of interventions at improving infant
sleep did not show a clear impact on infant night waking (signaling) or maternal depression
(Douglas and Hill, 2013). A recent meta-analysis found an effect of infant sleep interventions
on maternal depressive symptoms measured using the Edinburgh Postnatal Depression Scale
(EPDS). Although, the authors comment that the two highest quality studies in their review
did not report a significant association between infant sleep interventions and maternal mood
(Kempler et al., 2016).
An infant-driven model is conceptualized to start with an unsettled infant as a risk
factor for the development of maternal depressive symptoms. A study that prospectively
examined women who presented with an EPDS score less than 13 at one week postpartum
and elevated EPDS scores at four and eight weeks postpartum, also reported fatigue and an
unsettled infant with poor sleep (Dennis and Ross, 2005). A randomized control trial aimed at
reducing depression and infant sleep problems demonstrated a small but significant reduction
in depressive symptoms between four and six months postpartum for mothers in the
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
7
intervention arm. It should be noted, however, that for the intervention group, the average
EPDS was 6.3 (SD = 4.4) at four months and 5.1 (SD = 4) at 6 months, suggesting that this
sample was a low-risk sample for clinical depression (Hiscock et al., 2014). Few studies have
used diagnostic measures for depression, with the majority relying on EPDS; as such,
implications for depressive disorders cannot be drawn from this literature. Beyond the
maternal- and infant-driven models, a range of environmental factors are often not examined
in studies investigating infant sleep and maternal depression, but may equally influence both
maternal depression and infant sleep. These factors include in-utero exposures including
antidepressant medication and early parenting practices such as breastfeeding and infant sleep
location.
The use of antidepressant medication in pregnancy for women experiencing moderate
to severe depression is rising and hence understanding any influence on infant sleep
development is important. The most commonly prescribed antidepressant is a Selective
Serotonergic Reuptake Inhibitor (SSRI), which has been shown to alter maternal sleep
architecture, but as yet there is only limited exploration of the potential effect of fetal
exposure on the development of infant sleep architecture (Jindal et al., 2003). One study of
fetuses exposed to SSRIs throughout pregnancy reported disrupted development of quiet
sleep in late pregnancy, but follow-up into the postpartum was not undertaken (Mulder et al.,
2011). Studies that examine neonatal behavior following exposure to SSRIs identify sleep
changes as one of the most common symptoms (Galbally et al., 2017a; Zeskind and Stephens,
2004). However, again, follow-up beyond the neonatal period is limited. These studies also
rely on a script having been given or a hospital record yet many women discontinue treatment
with antidepressants in pregnancy (Ververs et al., 2006).
In this study, we built on existing research to examine the associations between
maternal depression and antidepressant use, and infant sleep. First, we assessed the role of
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
8
antidepressant exposure on infant sleep behaviors, including total nocturnal sleep time and
nocturnal waking. As per previous findings, we predicted that the sleep behaviors of infants
exposed to antidepressants would differ significantly compared to the sleep behaviors infants
not exposed to antidepressants (hypothesis 1). For infant sleep behaviors that did vary, we
predicted a dose effect of antidepressants, such that higher doses would be associated with
stronger effects (hypothesis 2).
Next, we assessed the role of clinically diagnosed maternal depressive disorder on
infant sleep location, perception of sleep problems, support seeking for infant sleep problems,
and use of parental bedtime settling strategies and behaviors. We predicted that mothers with
a depressive disorder would be more likely to report different sleeping locations, and infant
sleep perceptions, strategy use and behaviors compared to mothers not diagnosed with a
depressive disorder (hypothesis 3). We also examined the role of a maternal depressive
disorder on infant sleep behaviors at 6 and 12 months postpartum, testing the effect of
breastfeeding as a moderator. Specifically, we predicted a significant interaction between
maternal depressive disorder and breastfeeding on infant sleep behaviors (hypothesis 4).
Finally, we extended the models for maternal depressed mood and infant sleep
reported by Teti and Crosby (2012) by combining the mother- and infant-driven models,
testing simultaneously the longitudinal effects of maternal depressive disorder and symptoms
during pregnancy and the postpartum, and how these symptoms were associated with
nocturnal infant waking in the postpartum, controlling for breastfeeding. Specifically, we
predicted that the relations between postpartum maternal depressive symptoms and infant
waking would be bidirectional, after controlling for antepartum depressive disorder and
symptoms and breastfeeding in the postpartum (hypothesis 5). We also predict maternal
bedtime settling behavior and maternal cognitions about infant sleep in the postpartum will
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
9
be associated with maternal depressive symptoms and infant waking at 6 and 12 months
postpartum (hypothesis 6).
Method
This is a prospective cohort study of 282 pregnant women recruited before the 20th
week of pregnancy (Wave 1), and followed up during third trimester (Wave 2), birth of their
child (Wave 3), and six months (Wave 4), 12 months (Wave 5) and 36 months postpartum
(Wave 6). For this study, 264 women (Mage = 31.21, SDage = 4.69, range: 18 – 48 years old)
were included using data from Waves 1, 2, 4 and 5. Women are missing if they had
withdrawn prior to or after Wave 3 or if they were missing both postpartum waves. Study
participants comprised three groups: women taking antidepressant medication in pregnancy
(AD exposed; n = 47), non-medicated women who met diagnostic criteria for depression or
dysthymia at recruitment (Depressed; n = 29), and control women (n = 189). Further details
of the study are described in the published study protocol (Galbally et al., 2017b). Mercy
Health Human Research Ethics Committee approved this study and all participants provided
informed, written consent.
Measures
Mother reported whether they had ceased breastfeeding at 6 and 12 months
postpartum (0 = ceased breastfeeding, 1 = breastfeeding), and whether their infant slept in
the same room (0 = own room, 1 = parents’ room) and on the same surface (0 = own surface,
1 = parents’ surface).
A diagnostic measure was undertaken at recruitment: the Structured Clinical
Interview for DSM-IV (SCID-IV) Mood disorders schedule (First et al., 1997). In addition,
the Edinburgh Postnatal Depression Scale (EPDS) was administered at Waves 1, 2, 4 and 5
(Cox et al., 1987). The scale has been validated for use with Australian women during the
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
10
perinatal period, where sensitivity and specificity for cut-off scores of 12.5 and 13.5 were 100
and 95.7%, respectively (Boyce et al., 1993).
Antidepressant type, usage, dosage and timing during pregnancy was self-reported by
women, as well as obtained from hospital records at delivery. As the majority of participants
were on sertraline, all doses of antidepressants were converted to a sertraline-equivalent
dosage using a conversion chart (Procyshyn et al., 2015). Participant-reported antidepressant
dose during the first trimester is used for this analysis.
Maternal blood and umbilical cord blood were also collected within 30 minutes of
delivery and assayed for drug levels. Blood was centrifuged and the plasma stored at -80°C
within one hour of collection. All samples were analyzed with liquid chromatography with
mass spectrometry or tandem mass spectrometry, with methods described previously
(Andreassen et al., 2015; Reis et al., 2009). The assay levels for each antidepressant type
were standardized by relating the concentrations measured to the middle of the therapeutic
range for the same drug (Hiemke et al., 2011) so that concentration levels were comparable
across the variety of applied antidepressants.
The Brief Infant Sleep Questionnaire (BISQ), a 13-item parent report measure,
administered at both postpartum waves to assess duration and quality of infant sleep during
the previous week. Individual items measure the following: nocturnal and diurnal sleep
duration (hours), nocturnal infant waking (referred to as infant signaling) (frequency), and
duration of nocturnal wakefulness duration and nocturnal sleep-onset (minutes). Also
measured is the degree to which the mother believes the infant’s sleeping is a problem (A
very serious problem, A small problem, and Not a problem at all) (Sadeh, 2004).
The Parental Interactive Bedtime Behavior Scale (PIBBS) is a 17-item scale to assess
a range of parental behaviors used to settle infants to sleep and was administered at 12
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
11
months postpartum (Morrell and Cortina‐Borja, 2002). Domains of settling behavior include
physical comforting, encouraging autonomy, movement, passive physical comforting, and
social comforting. Each item is measured using a 5-point Likert scale (0 = Never, 4 = Very
Often). We used a total score, computed to represent the percentage (ranging 0 to 100%) of
time mothers report using these strategies to settle their child at bedtime. The subscales have
been demonstrated as reliable and valid in several samples (Morrell and Cortina‐Borja, 2002).
We used three items from the Setting Limits subscale of the Maternal Cognitions
about Infant Sleep Questionnaire to operationalize mothers’ cognitions about their child’s
sleep described as maternal sleep cognitions within this study (Morrell, 1999). Each item is
measured using a 6-point Likert scale (0 = Strongly agree, 5 = Strongly disagree). The items
were “It is alright to let my child cry at night”, “My child will feel abandoned if I don’t
respond immediately to his/her cries at night” and “I should respond straightaway when my
child wakes crying at night”. Prior to averaging, the second and third items were reverse-
coded, which resulted in higher scores indicating mothers’ who had trouble resisting their
children’s crying at night. In our data, these items demonstrated good internal consistency at
both six (α = .81) and 12 months (α = .76) postpartum.
Data Analyses
We used SPSS version 24 (IBM Corp., 2016) to conduct analyses for hypotheses 1 to
4. To address hypothesis 1, we presented infant sleep outcomes (BISQ) at 6 and 12 months
post-partum for women taking antidepressants and women not antidepressants, accompanied
by inferential tests (F and χ2
tests) to determine the significance of group differences. When
variance between groups differed significantly, we presented the result of the more robust
Welch F test. To address hypothesis 2, we presented Spearman’s correlations to test for
associations between antidepressant dose and sleep outcomes that differ between AD exposed
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
12
versus not exposed. These associations were only tested in the subset of women exposed to
antidepressants and provided maternal and cord blood following labor (n = 42).
To address hypothesis 3, we presented infant sleep location, and maternal perceptions
and behaviors relating to infant sleep for depressed and non-depressed women, comparing
differences inferentially using a series of bivariate logistic regressions. For hypothesis 4, we
conducted a series of factorial (2x2) analysis of variance tests, using the BISQ outcomes for
both postpartum waves, testing the interaction between depressive disorder groups and
breastfeeding.
To address hypothesis 5 that postnatal maternal depression and infant waking were
bidirectional associations even when controlling for antenatal depression and breastfeeding
and hypothesis 6 that postpartum depression and infant sleep will be associated with maternal
cognitions and behaviours we used Mplus version 8 (Muthén and Muthén, 1998-2012) to
analyse these models. The conceptual overall model, including nested models, to be tested are
presented in Figure 1. Figure 2 presents the best fitting model following model testing
analyses. We describe the steps to reach this below.
To undertake this analysis for hypothesis 5 and 6 we first conducted a series of nested
cross-lagged panel models, using repeat measures at first and third trimester, and six and 12
months postpartum. As data were multivariate non-normal, we used maximum likelihood
with robust standard errors (MLR) to estimate the models, with data missing at random
estimated using full-information maximum-likelihood. We then followed the cross-lagged
panel modelling process described by Geiser (2013). Progressively less constrained models
were compared using Satorra’s (Bryant and Satorra, 2012) scaled Chi-square difference tests
and the Akaike Information Criteria (AIC) value. The best fitting model was presented in
Figure 2 to address study hypotheses 5 and 6. We considered Comparative Fit Index (CFI) ≥
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
13
.95, Root Mean Square Error of Approximation (RMSEA) ≤ .05, and Standardized Root
Mean Square (SRMR) ≤ .08 to indicate a model that fit the data well Hu and Bentler (1999).
The nested models presented conceptually in Figure 1 were tested and are described
below. The best fitting model from this process is presented in Figure 2. Model 1 is the
baseline model comprising paths a through e, inclusive; this model formed the basis of
comparison for subsequent less constrained models. In this model, all first- and second-order
autoregressive paths for depressive symptoms scores and first-order autoregressive paths for
cognitions about infant sleep and infant signaling were estimated (a paths). Pathways
between both antepartum depression and depressive symptoms at third trimester with six-
month postpartum infant signaling and cognitions about infant sleep were estimated (b paths).
Cross-sectional pathways between breastfeeding and infant signaling at six and 12 months
postpartum were also estimated (c paths). Finally, covariances were estimated between cross-
sectional measurements to account for contemporaneous associations.
<Figure 1>
In model 2, pathways were estimated originating from depressive symptoms at 6-
months to cognitions about infant sleep, bedtime settling behaviors and infant signaling all at
12 months (f paths). In model 3, pathways were estimated originating from infant signaling at
6-months to depressive symptoms, bedtime settling behaviors and cognitions about infant
sleep all at 12 months (g paths). In model 4, pathways were estimated originating from
cognitions about infant sleep at 6-months to depressive symptoms, bedtime settling behaviors
and infant signaling all at 12 months (h paths). In the final model (Model 5), all cross-lagged
pathways were included (paths f, g and h) to estimate the full cross-lagged model.
Results
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
14
As predicted in our first hypothesis, we expected antidepressant exposure to influence
sleep outcomes (Table 1). Infants differed only at six months postpartum in the average
number of hours they were sleeping at night, such that infants with AD exposure slept for a
significantly shorter period between 7pm and 7am. All other comparisons between the groups
were not significant (p > .01).
<Table 1>
None of the correlations for infant nocturnal sleep duration with sertraline-equivalent
dose, and maternal and cord plasma were significantly different from zero (Supplementary
Table 1). This suggests there is no evidence of a dosage effect of antidepressant exposure on
duration of sleep at night in infants at both 6 and 12 months post-partum.
Regarding maternal depression and infant sleep, depressed women were nearly three
times more likely to be sleeping on the same surface as their infant at six months, compared
to control women (Table 2). At 12 months postpartum, depressed women were twice as likely
to be sleeping in the same room as their child, compared to healthy women. The two groups
did not differ on any of the other measures, including bedtime settling behaviors.
<Table 2>
For the factorial ANOVAs, none of the main effects for the depression groups were
significant and none of the interactions between breastfeeding and depression for infant sleep
outcomes were significant. However, mothers who were still breastfeeding at six months
reported significantly more nocturnal infant signaling at six months (M = 2.28, SD = 1.70)
compared to those mothers who had stopped breastfeeding (M = 1.18, SD = 1.01), F(1, 213)
= 17.29, p < .001. This pattern was the same at 12 months, with mothers still breastfeeding
reporting significantly more infant signaling at night (M = 1.85, SD = 1.50) compared to
those mothers who had stopped breastfeeding (M = 1.12, SD = 1.02), F(1, 175) = 14.88, p <
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
15
.001. None of the other infant sleep outcomes (BISQ) differed between the breastfeeding
groups at either wave.
Table 3 displays zero-order bivariate correlation coefficients and descriptive statistics
for all variables included in the modelling. Table 4 displays the results of the nested cross-
lagged model comparison testing.
<Table 3>
<Table 4>
Model 1 was an adequate fit to the data (CFI = .94, RMSEA = .06 [.04, .08], SRMR =
.08). Adding the crossed effects of depressive symptoms at six months postpartum to infant
signaling, bedtime settling behavior and cognitions about infant sleep all at 12 months (i.e.,
Model 2), did not improve upon the fit of Model 1. This suggests that early postpartum
depressive symptoms are not predictive of later postpartum infant nocturnal signaling.
Adding the crossed effects of infant signaling at six months postpartum to depressive
symptoms, bedtime settling behavior and maternal limit setting cognitions about infant sleep
all at 12 months postpartum (i.e., Model 3), significantly improved the fit of Model 1. So too,
the addition of pathways between cognitions about infant sleep at six months and depressive
symptoms, bedtime settling behavior and infant signaling (i.e., Model 4), improved the fit of
Model 1. Given Model 2 did not improve on the fit of Model 1, the f paths in Figure 1
(online) were not included in the final cross-lagged model (Model 5). Model 5 was a better fit
compared to all other models (CFI = .98, RMSEA = .04 [.00, .06], SRMR = .05), suggesting
that over and above the effects of antepartum depression, depressive symptoms, breastfeeding
and autoregressive paths, early postpartum infant signaling and cognitions about infant sleep
are significantly associated with later postpartum infant signaling, cognitions about infant
sleep and bedtime settling behaviors.
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
16
Figure 2 displays significant path coefficients for Model 5. Antepartum depressive
symptoms were only significantly associated with postpartum depressive symptoms via first-
and second-order autoregressive paths. Antepartum depressive disorder measured on the
SCID-IV did not predict any of the postpartum measures, including depressive symptoms. At
six months postpartum, breastfeeding was associated with significantly more infant signaling;
however, by 12 months, the cross-sectional association was not significant. There were no
significant bidirectional associations between depressive symptoms and infant signaling;
therefore, we reject hypothesis 5. Only one non-autoregressive path was a significant
predictor of depressive symptoms: higher maternal sleep cognitions regarding setting infant
sleep limits at six months were associated with higher depressive symptoms at 12 months.
<Figure 2>
Although there were no significant cross-lag paths between postpartum depressive
symptoms and infant signaling in the postpartum, there were significant cross-lag paths
between maternal cognitions about infant sleep and infant signaling. Higher maternal infant
sleep cognitions at six months predicted more infant signaling at 12 months, and more infant
signaling at six months predicted higher maternal sleep cognitions at 12 months. Comparison
of the standardized coefficients suggests that the earlier effect of sleep cognitions on later
signaling (β = .18) is slightly stronger than the earlier effect of infant signaling on later
maternal sleep cognitions (β = .16). More infant signaling and higher sleep cognitions at six
months were both significantly predictive of mothers spending more time engaged in bedtime
infant sleep behaviors at 12 months. As the cross-lagged paths for depressive symptoms were
not included in the final model and six month infant signaling did not directly predict
depressive symptoms, the two-wave mediation analyses were not undertaken. Therefore,
there is no support for hypothesis 6, which predicted mediation between infant signaling and
depressive symptoms through maternal sleep cognitions and bedtime settling behaviors.
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
17
Discussion
Our findings do not support a relationship between either earlier maternal depression
predicting later infant sleep outcomes, or earlier increased infant nocturnal signaling
predicting later depression. Maternal cognitions regarding setting limits for infant sleep, such
as concern their baby will feel abandoned if not immediately responded to at night, did
predict depressive symptoms at 12 months of age and these maternal cognitions also
predicted increased nocturnal signaling at 12 months and increased active maternal bedtime
comforting behaviors. Despite the lack of support from the cross-lagged paths between
maternal depression and infant signaling, there was a significant positive contemporaneous
association between maternal depressive symptoms and infant signaling at six months.
Of note, there was no association with fetal antidepressant exposure and sleep
development in infants and this study utilized robust measures of exposure ranging from
prospective self-report and hospital records through to both maternal and cord blood levels to
increase certainty of exposure (Galbally et al., 2017a). Similarly, depression was not
associated with perceived infant sleep problems or settling behaviors using a diagnostic
measure of depression in pregnancy or self-report symptoms across the perinatal period.
However, depression was associated with an increase in likelihood that an infant would share
a bed surface six months and a room at 12 months postpartum. Breastfeeding was associated
with increased infant night signaling at six and 12 months and women who were on
antidepressant medication had infants who slept less overnight, and as previously, reported
also breastfed more frequently, which persisted to 12 months of age (Galbally et al., 2018, in-
press).
Infant sleep development begins in utero and continues across the neonatal, infancy
and early childhood periods. Sleep gradually decreases in quantity but increases in
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
18
consolidated periods following a rhythm across day and night, and sleeping through the night
is an important milestone in developmental maturity (Mirmiran et al., 2003). Research into
sleep development suggest a range of important biological factors, which include gestation at
birth, demand breastfeeding where maternal melatonin contained in milk will match the time
of day for the infant, light/dark exposure, and maternal sleep regulation (Mirmiran et al.,
2003). Beyond these biological factors is also the environmental context that infant sleep
development occurs within including parenting practices and expectations around infant sleep
that can vary across individuals, families and cultures. Therefore, understanding infant sleep
problems needs to be in the context of an understanding of the developmental and changing
nature of infant sleep over the first year of life.
Research into understanding the relationship between infant sleep and maternal
depression has been hampered by measurement and methodological concerns. These include
the definition of infant sleep problems as well as the measurement of maternal depression.
For instance, within a normal sleep cycle for infants, there is brief waking; however, reports
of infant signaling in the night suggests the infant wakes and is unable to re-settle and signals
to the parent, but this is often defined in studies without distinguishing if a baby is waking to
breastfeed or is truly unsettled overnight (Keener et al., 1988). Given the majority of
breastfed babies will continue to feed regularly overnight to at least 6 months of age and may
need to signal to ensure they are fed, the reason for waking is an important consideration
when defining a sleep problem (Galbally et al., 2013; Hörnell et al., 1999). Likewise, settling
to sleep at night is influenced by parenting sleep practices, sleep location and may reflect
aspects of the mother-infant relationship (Beijers et al., 2011; Sadeh et al., 2016; Teti et al.,
2010). Furthermore, an important aspect of understanding the quality of early mother-infant
relationship is the role of maternal depression given the well-characterized effect this may
have on the mother-infant relationship. Yet typically, when maternal depression is included in
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
19
studies of infant sleep, measurement has relied on screening self-report measures in low-risk
populations.
While poor infant sleep is associated with poorer child developmental outcomes,
research that has focused on breastfeeding has not found an association with adverse child
development outcomes (Quinn et al., 2001; Sadeh et al., 2015). It may be that signaling to a
caregiver overnight when it does not impact on sleep quantity may not be detrimental for
developmental outcomes, but represent a relational response to nighttime parenting practices.
While we found breastfeeding was associated with increased night signaling previously, we
have not found an increase in depression in breastfeeding women in this sample (Galbally et
al., 2018, in-press). Furthermore, a focus on interventions aimed at extinguishing infant
night-time signaling may have an unwanted effect of reducing the public health goal of
improving breastfeeding duration. Therefore, studies that examine depression and infant sleep
need to include feeding method and find methods that distinguish infant night waking for
feeding from true infant sleep problems.
Our findings were drawn from Anglophone populations and as such, it was not
possible to explore the cultural diversity of early parenting practices around infant sleep,
which may also be relevant for maternal depression. However, there is evidence that in
cultures where infant sleep practices are significantly different, for instance in Japan where
there are higher rates of bed sharing, both night waking and associated signaling through cry
is common and it is unclear if this may relate to maternal depression (Fukumizu et al., 2005;
Latz et al., 1999). Future research would benefit from replication in other cultural contexts
would be useful to understand if infant sleep practices influence this model. A further
limitation was the reliance on maternal report for infant sleep. This study would be enhanced
by the use of objective sleep measures for both mother and infant.
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
20
The strengths of this study include the careful characterization of maternal depression
across pregnancy and the postpartum, and including data on treatment of depression with
antidepressant medication. Infant sleep outcomes and associated parenting behaviors around
infant sleep were also operationalized using several measures, including infant behavior,
parenting settling techniques and maternal cognitions about sleep. Breastfeeding, a common
confounding variable when considering infant sleep, was also controlled for in our models.
This allowed us to untangle the presence of additive effects of both maternal depressive
symptoms and cognitions on infant signaling, beyond normal waking for feeding.
Future research is required to understand how maternal mental health in pregnancy
may also influence these signals such as through maternal cortisol and melatonin in the
development of infant sleep. This could be through fetal programming mechanisms such as
explored in other areas of research on maternal depression and child outcomes (Gentile,
2017; Lewis et al., 2014). Equally though, studies need to examine mental health and key
postpartum variables such as the social, cultural and psychological factors including
breastfeeding, parenting strategies and sleep practices, which may also influence infant sleep.
It is only through this level of sophisticated research that we will understand the important
relationship between maternal depression and infant sleep and most important translate this
knowledge into evidence based guidance, recommendations and interventions for women and
children. Overall, our findings suggest a focus on maternal treatment is important for
understanding infant night waking and further research could examine whether effective
treatment of depression assists infant sleep behaviors and development.
Contributors
MG and AL proposed the original study. MG, AL and DT designed the overall study. SW,
MG and AL contributed to the planning and undertaking the statistical analysis and all
authors contributed to the interpretation of findings. MG and SW prepared the draft of the
paper and all authors critically reviewed and revised for content and gave approval to the
final to be published version of the manuscript.
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
21
Role of the Funding Source
The organizations that funded the study did not contribute to any of the following elements of
the paper: study design, the collection, analysis, and interpretation of data, the writing of the
report, and the decision to submit the paper for publication.
Conflict of Interest
MG has previously received honorarium for speaking from Lundbeck. The other authors
declare that they have no competing interests.
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
22
Acknowledgements
The authors would like to thank those who have both supported and given advice in the
development of MPEWS including: Marinus van IJzendoorn, Michael Permezel, Anne Buist,
Philip Boyce, Marie-Paule Austin, Peter Fonagy, Robert Emde, Marian Bakermans-
Kranenburg and Michelle Leech. The authors also thank the staff and students on the study
and research coordinators: Tina Vaiano and Nicole Brooks and volunteer Susan Pitchford for
their contribution to MPEWS. Thank you also to Carole Branch at Mercy Health Human
Research Ethics Committee. We are also sincerely grateful to the study participants who have
contributed a substantial amount of time to participating in this study.
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
23
References
Andreassen, T.N., Falch, B.M., Spigset, O., 2015. A UPLC-MSMS method for the analysis of olanzapine in serum-with particular emphasis on drug stability testing. Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences 1006, 112-120. Beijers, R., Jansen, J., Riksen-Walraven, M., de Weerth, C., 2011. Attachment and infant night waking: A longitudinal study from birth through the first year of life. Journal of Developmental & Behavioral Pediatrics 32, 635-643. Boyce, P., Stubbs, J., Todd, A., 1993. The Edinburgh Postnatal Depression Scale: Validation for an Australian Sample. Australasian Psychiatry 27, 472-476. Bryant, F.B., Satorra, A., 2012. Principles and Practice of Scaled Difference Chi-Square Testing. Structural Equation Modeling: A Multidisciplinary Journal 19, 372-398. Cox, J.L., Holden, J.M., Sagovsky, R., 1987. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. The British journal of psychiatry 150, 782-786. Dennis, C.L., Ross, L., 2005. Relationships among infant sleep patterns, maternal fatigue, and development of depressive symptomatology. Birth 32, 187-193. Dias, C.C., Figueiredo, B., 2015. Breastfeeding and depression: a systematic review of the literature. Journal of Affective Disorders 171, 142-154. Douglas, P.S., Hill, P.S., 2013. Behavioral sleep interventions in the first six months of life do not improve outcomes for mothers or infants: a systematic review. Journal of Developmental & Behavioral Pediatrics 34, 497-507. Field, T., Diego, M., Hernandez-Reif, M., Figueiredo, B., Schanberg, S., Kuhn, C., 2007. Sleep disturbances in depressed pregnant women and their newborns. Infant Behavior and Development 30, 127-133. First, M., Spitzer, R., Gibbon, M., Williams, J., 1997. Stuructured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinical Version. Washington DC and London. American Psychiatric Press, Inc. Fisher, J., Feekery, C., Rowe, H., 2004. Treatment of maternal mood disorder and infant behaviour disturbance in an Australian private mothercraft unit: a follow-up study. Archives of Women's Mental Health 7, 89-93. Fukumizu, M., Kaga, M., Kohyama, J., Hayes, M.J., 2005. Sleep-related nighttime crying (yonaki) in Japan: a community-based study. Pediatrics 115, 217-224. Galbally, M., Lewis, A.J., McEgan, K., Scalzo, K., Islam, F.A., 2013. Breastfeeding and infant sleep patterns: an Australian population study. Journal of Paediatric Child Health 49, E147-152. Galbally, M., Spigset, O., Johnson, A.R., Kohan, R., Lappas, M., Lewis, A.J., 2017a. Neonatal adaptation following intrauterine antidepressant exposure: Assessment, drug assay levels and infant development outcomes. Pediatric Research. Galbally, M., van, I.M., Permezel, M., Saffery, R., Lappas, M., Ryan, J., van Rossum, E., Johnson, A.R., Teti, D., Lewis, A.J., 2017b. Mercy Pregnancy and Emotional Well-being Study (MPEWS): Understanding maternal mental health, fetal programming and child development. Study design and cohort profile. International Journal of Methods in Psychiatric Research. Galbally, M., Watson, S., Ball, H., Lewis, A.J., 2018, in-press. Breastfeeding, Antidepressants and Depression in the Mercy Pregnancy and Emotional Wellbeing Study. Journal of Human Lactation. Geiser, C., 2013. Data Analysis with Mplus. The Guildford Press, New York, NY. Gentile, S., 2017. Untreated depression during pregnancy: Short-and long-term effects in offspring. A systematic review. Neuroscience 342, 154-166. Hiemke, C., Baumann, P., Bergemann, N., Conca, A., Dietmaier, O., Egberts, K., Fric, M., Gerlach, M., Greiner, C., Gründer, G., Haen, E., Havemann-Reinecke, U., Jaquenoud Sirot, E., Kirchherr, H., Laux, G., Lutz, U.C., Messer, T., Müller, M.J., Pfuhlmann, B., Rambeck, B., Riederer, P., Schoppek, B., Stingl, J., Uhr, M., Ulrich, S., Waschgler, R., Zernig, G., 2011. AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011. Pharmacopsychiatry 21, 195-235.
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
24
Hiscock, H., Cook, F., Bayer, J., Le, H.N., Mensah, F., Cann, W., Symon, B., St James-Roberts, I., 2014. Preventing early infant sleep and crying problems and postnatal depression: a randomized trial. Pediatrics 133, e346-354. Hiscock, H., Wake, M., 2001. Infant sleep problems and postnatal depression: a community-based study. Pediatrics 107, 1317-1322. Hörnell, A., Aarts, C., Kylberg, E., Hofvander, Y., Gebre‐Medhin, M., 1999. Breastfeeding patterns in exclusively breastfed infants: a longitudinal prospective study in Uppsala, Sweden. Acta paediatrica 88, 203-211. Hu, L.t., Bentler, P.M., 1999. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling: A Multidisciplinary Journal 6, 1-55. IBM Corp., 2016. IBM SPSS Statistics for Windows, 24 ed. IBM Cop., Armonk, NY. Jindal, R.D., Friedman, E.S., Berman, S.R., Fasiczka, A.L., Howland, R.H., Thase, M.E., 2003. Effects of sertraline on sleep architecture in patients with depression. Journal of clinical psychopharmacology 23, 540-548. Keener, M.A., Zeanah, C.H., Anders, T.F., 1988. Infant temperament, sleep organization, and nighttime parental interventions. Pediatrics 81, 762-771. Kempler, L., Sharpe, L., Miller, C.B., Bartlett, D.J., 2016. Do psychosocial sleep interventions improve infant sleep or maternal mood in the postnatal period? A systematic review and meta-analysis of randomised controlled trials. Sleep medicine reviews 29, 15-22. Lam, P., Hiscock, H., Wake, M., 2003. Outcomes of infant sleep problems: a longitudinal study of sleep, behavior, and maternal well-being. Pediatrics 111, e203-207. Latz, S., Wolf, A.W., Lozoff, B., 1999. Cosleeping in context: sleep practices and problems in young children in Japan and the United States. Archives of pediatrics & adolescent medicine 153, 339-346. Lewis, A.J., Galbally, M., Gannon, T., Symeonides, C., 2014. Early life programming as a target for prevention of child and adolescent mental disorders. BMC medicine 12, 33. Mirmiran, M., Maas, Y.G., Ariagno, R.L., 2003. Development of fetal and neonatal sleep and circadian rhythms. Sleep Medicine Reviews 7, 321-334. Morrell, J., Cortina‐Borja, M., 2002. The developmental change in strategies parents employ to settle young children to sleep, and their relationship to infant sleeping problems, as assessed by a new questionnaire: The Parental Interactive Bedtime Behaviour Scale. Infant and Child Development 11, 17-41. Morrell, J.M.B., 1999. The Role of Maternal Cognitions in Infant Sleep Problems as Assessed by a New Instrument, the Maternal Cognitions about Infant Sleep Questionnaire. The Journal of Child Psychology and Psychiatry and Allied Disciplines 40, 247-258. Mulder, E.J., Ververs, F.F., De Heus, R., Visser, G.H., 2011. Selective serotonin reuptake inhibitors affect neurobehavioral development in the human fetus. Neuropsychopharmacology 36, 1961. Muthén, L.K., Muthén, B.O., 1998-2012. Mplus User's Guide, 7th ed. Muthén & Muthén, Los Angeles, CA. Nevarez, M.D., Rifas-Shiman, S.L., Kleinman, K.P., Gillman, M.W., Taveras, E.M., 2010. Associations of early life risk factors with infant sleep duration. Academic pediatrics 10, 187-193. Procyshyn, R.M., Bezchlibnyk-Butler, K.Z., Jeffries, J.J., 2015. Clinical handbook of psychotropic drugs. Hogrefe Publishing. Quinn, P.J., O'Callaghan, M., Williams, G.M., Najman, J.M., Andersen, M., Bor, W., 2001. The effect of breastfeeding on child development at 5 years: a cohort study. Journal of paediatrics and child health 37, 465-469. Reis, M., Aamo, T., Spigset, O., Ahlner, J., 2009. Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database. Therapeutic Drug Monitoring 31, 42-56. Sadeh, A., 2004. A brief screening questionnaire for infant sleep problems: validation and findings for an Internet sample. Pediatrics 113, e570-577.
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
25
Sadeh, A., De Marcas, G., Guri, Y., Berger, A., Tikotzky, L., Bar-Haim, Y., 2015. Infant sleep predicts attention regulation and behavior problems at 3–4 years of age. Developmental Neuropsychology 40, 122-137. Sadeh, A., Juda‐Hanael, M., Livne‐Karp, E., Kahn, M., Tikotzky, L., Anders, T.F., Calkins, S., Sivan, Y., 2016. Low parental tolerance for infant crying: an underlying factor in infant sleep problems? Journal of Sleep Research 25, 501-507. Teti, D., Crosby, B., 2012. Maternal Depressive Symptoms, Dysfunctional Cognitions, and Infant Night Waking: The Role of Maternal Nighttime Behavior. Child Development 83, 939-953. Teti, D., Kim, B.R., Mayer, G., Countermine, M., 2010. Maternal emotional availability at bedtime predicts infant sleep quality. Journal of Family Psychology 24, 307-315. Ververs, T., Kaasenbrood, H., Visser, G., Schobben, F., de Jong-van den Berg, L., Egberts, T., 2006. Prevalence and patterns of antidepressant drug use during pregnancy. European journal of clinical pharmacology 62, 863-870. Zeskind, P.S., Stephens, L.E., 2004. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 113, 368-375.
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
26
Figure 1. Full cross-lagged panel model.
Figure 2. Model 5 cross-lag panel model results (N = 254). Greyed-out, dashed lines denote
non-significant paths. Percentages represent explained variance (i.e., R2). *p < .05 **p < .01
***p < .001.
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
27
Table 1. Mean (SD) differences for infant sleep outcomes (BISQ) at 6 and 12 months postpartum
between mothers not exposed to antidepressants and mothers exposed to antidepressants (N = 264).
Not Exposed
to AD
(n = 217)
Exposed to
AD
(n = 47) F p
BISQ at 6 Months Postpartum
Nocturnal sleep duration (hours) 10.08 (1.34) 9.52 (1.64) 5.43 .021
Daytime sleep duration (hours) 3.60 (1.51) 3.82 (1.36) 0.72 .397
Nocturnal infant signalling (frequency) 1.98 (1.44) 2.44 (2.17) 1.67† .203
Duration of night wakefulness (minutes) 38.04 (43.77) 52.61 (62.83) 3.11 .079
Nocturnal sleep onset (minutes) 28.14 (29.49) 31.10 (30.93) 0.34 .560
BISQ at 12 Months Postpartum
Nocturnal sleep duration (hours) 10.50 (1.24) 10.16 (1.74) 2.05 .154
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
28
Daytime sleep duration (hours) 2.51 (1.23) 2.28 (.85) 1.14 .286
Nocturnal infant signalling (frequency) 1.46 (1.45) 1.50 (.96) 0.05† .822
Duration of night wakefulness (minutes) 33.16 (78.36) 31.78 (35.93) 0.01 .922
Nocturnal sleep onset (minutes) 21.39 (16.52) 25.62 (25.49) 0.86† .359
† Welch F Test due to significant heterogeneity of group variances.
Table 2. Infant sleep outcomes (BISQ; n, %) and bedtime settling behaviours (PIBBS; M,
SD) between depressed and non-depressed mothers (diagnosed using the SCID-IV; N = 264).
Not Depressed
(n = 206)
Depressed
(n = 58)
n (%) n (%) OR [95% CIs]
Infant Sleep Arrangements
Sharing surface at 6 months 20 (10.8) 11 (21.6) 2.83 [1.01, 5.14]
Sharing surface at 12 months 44 (23.7) 12 (23.5) 1.72 [.77, 3.82]
Sleeping in parents' room at 6
months
64 (34.4) 23 (45.1) 1.57 [.84, 2.94]
Sleeping in parents' room at 12
months
43 (25.9) 17 (42.5) 2.11 [1.03, 4.33]
Perceived Infant Sleep Problem at 6
months
86 (45.7) 22 (42.3) .87 [.47, 1.62]
Perceived Infant Sleep Problem at 12
months
88 (50.0) 20 (47.6) .91 [.46, 1.78]
Sought Help for Infant Sleep Problem at
12 months (%)
54 (30.7) 13 (31.0) 1.01 [.49, 2.10]
Use Bedtime Sleep Strategy at 12 72 (41.1) 18 (43.9) 1.12 [.56, 2.22]
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
29
months (%)
M (SD) M (SD) F (p-value)
PIBBS Total at 12 Months 30.05 (8.87) 28.57 (7.50) 0.349
Active Physical Comforting 20.86 (14.34) 20.94 (13.50) 0.974
Encourage Autonomy 18.91 (14.11) 17.31 (12.88) 0.517
Settle by Movement 11.56 (17.10) 8.13 (14.86) 0.243
Passive Physical Comforting 14.97 (17.53) 9.94 (15.22) 0.099
Social Comforting 22.11 (16.28) 23.28 (16.81) 0.684
Note. BISQ, Brief Infant Sleep Questionnaire; PIBBS, Parent Interactive Bedtime Behaviours Scale;
SCID-IV; Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition.
Table 3. Descriptive statistics and zero-order bivariate correlations between all variables
included in the cross-lagged models (N = 264)
1 2 3 4 5 6 7 8 9 10 11
1
2
1. SCID-IV
Depressiona
(
W
1) -
2. Depressive
Symptoms
(
W
1)
.39
**
* -
3. Depressive
Symptoms
(
W
2)
.34
**
*
.67
**
* -
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
30
4. Depressive
Symptoms
(
W
4)
.28
**
*
.50
**
*
.56
**
* -
5. Depressive
Symptoms
(
W
5)
.30
**
*
.53
**
*
.59
**
*
.68
**
* -
6. Cognitive
Limit-setting
(
W
4)
-
.09
-
.08
-
.07 .01
-
.17
* -
7. Cognitive
Limit-setting
(
W
5)
-
.11
-
.12
-
.10
-
.05
-
.17
*
.68
*** -
8. Bedtime
Settling
Behaviours
(
W
5)
-
.04 .06 .03 .11
.15
*
-
.23
**
-
.19
** -
9. Nocturnal
Infant
Signalling
(
W
4) .05 .00 .04
.17
* .13
-
.19
**
-
.29
*** .22** -
10. Nocturnal
Infant
Signalling
(
W
5)
-
.07 .03
-
.04
.15
*
.17
*
-
.30
***
-
.32
***
.31**
*
.60
**
* -
11.
Breastfeedinga
(
W
4)
-
.05
-
.11
-
.14
*
-
.03
-
.19
** -.02 -.08 .19*
.24
**
*
.1
3 -
12. ( - .03 0.0 .02 - -.06 - .21** .27 .2 .50 -
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
31
Breastfeedinga W
5)
.10 1 .04 .16
*
**
*
5*
*
**
*
Mean
.22
6.5
5
6.3
5
5.9
5
6.4
6
3.0
0
3.3
9 29.91
2.0
4
1.
41 .76
.
3
7
Standard
Deviation
.41
4.7
4
4.5
3
4.5
5
4.8
9
1.2
4
1.2
4 8.65
1.6
0
1.
29 .43
.
4
8
Range
0-1
0-
27
0-
25
0-
24
0-
25 1-6 1-6
13.33-
65.83
0-
10
0-
7 0-1
0
-
1
bCorrelations with SCID-IV Depression and Breastfeeding Cessation are point-biserial
coefficients.
*p < .05 **p < .01 ***p < .001.
Table 4. Comparison of nested cross-lagged models
Model χ2 d.f.
Satorra-
Bentler
Scaled
Correction
Factor
Model
Comparison
Satorra-
Bentler
Scaled
Δχ2 Δd.f. AIC
M1: No Cross-lagged
Effects
75.07 37 1.03
8340.84
M2:Depressive
symptoms effects
72.12 34 1.02 M1 vs. M2 2.58 3 8343.19
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIP
T
32
M3: Infant Signalling
Effects
57.94 34 1.03 M1 vs. M3 16.63** 3 8329.52
M4: Infant Sleep
Cognition Effects
54.85 34 1.03 M1 vs. M4 19.63*** 3 8325.83
M5: Full Cross-lagged
Model
41.39 31 1.03 M1 vs. M5 32.74*** 3 8318.19
M2 vs. M5 33.60*** 3
M3 vs. M5 16.08** 3
M4 vs. M5 13.08** 3
**p < .01 ***p < .001